Portfolio

We’ve backed more than 40 Finnish technology companies. Around two thirds operate in the health, biotech, and environmental technology sectors, where Finnish innovation has worldwide relevance. Together, they represent a portfolio of ambitious companies building globally competitive solutions.

Many are now at a pivotal stage, with years of development behind them, commercial traction building and international expansion to come.

View portfolio
View exits

Growth companies in the Springvest portfolio

The view on this page reflects Springvest Corporation’s most recent financial report.

The most recently funded companies can be found on the investment platform.

Exits

Our portfolio companies have a strong track record of growth, with many since being acquired or listed. As with any investment portfolio, some companies have also ceased operations, as is the nature of investing in early-stage growth companies.

Acquired or publicly listed

1.5x

On average, investors have achieved approximately 1.5x returns at exit since Springvest’s founding.

IRR 17%

Investments on the platform have delivered an internal rate of return (IRR) of around 17%.

3.4 years

The average holding period for investments on Springvest has been approximately 3.4 years.

Other exits

Bankruptcies

  • Lynsight (2025)
  • Biomensio (2025)
  • MultiTaction (2022)
  • Biisafe (2022)
  • Medisapiens (2022)
  • Verto Analytics (2021)
  • ItsPure (2020)
  • Goodwiller (2020)
  • SignOn (2018)
  • Greenbiit (2015)
  • Neonella (2015)

Other exits

  • Fantastec
  • Linko (Inbot)
  • Minus Degree Mobile
  • Digital Fabric (Zadaa)
  • Ductor